• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

革兰氏阴性菌耐药的代价。

Cost of Gram-negative resistance.

作者信息

Evans Heather L, Lefrak Shayna N, Lyman Jason, Smith Robert L, Chong Tae W, McElearney Shannon T, Schulman Alison R, Hughes Michael G, Raymond Daniel P, Pruett Timothy L, Sawyer Robert G

机构信息

Department of Surgery, University of Virginia Health System, Charlottesville, VA, USA.

出版信息

Crit Care Med. 2007 Jan;35(1):89-95. doi: 10.1097/01.CCM.0000251496.61520.75.

DOI:10.1097/01.CCM.0000251496.61520.75
PMID:17110877
Abstract

OBJECTIVE

It is unclear that infections with Gram-negative rods resistant to at least one major class of antibiotics (rGNR) have a greater effect on patient morbidity than infections caused by sensitive strains (sGNR). We wished to test the hypothesis that rGNR infections are associated with higher resource utilization.

DESIGN

Retrospective observational cohort study of prospectively collected data.

SETTING

University hospital surgical intensive care unit and ward.

PATIENTS

Surgical patients with at least one GNR infection.

MEASUREMENTS

We compared admissions treated for rGNR infection with those with sGNR infections. Primary outcomes were total hospital costs and hospital length of stay. Other outcomes included antibiotic treatment cost, in-hospital death, and intensive care unit length of stay. After univariate analysis comparing outcomes after rGNR infection with those after sGNR infection, multivariate linear regression models for hospital cost and length of stay were created to account for potential confounders.

MAIN RESULTS

Cost data were available for 604 surgical admissions treated for at least one GNR infection (Centers for Disease Control and Prevention criteria), 137 (23%) of which were rGNR infections. Admissions with rGNR infections were associated with a higher severity of illness at the time of infection (Acute Physiology and Chronic Health Evaluation II score, 17.6 +/- 0.6 vs. 13.9 +/- 0.3), had higher median hospital costs ($80,500 vs. $29,604, p < .0001) and median antibiotic costs ($2,607 vs. $758, p < .0001), and had longer median hospital length of stay (29 vs. 13 days, p < .0001) and median intensive care unit length of stay (13 days vs. 1 day, p < .0001). Infection with rGNR within the first 7 days of admission was independently predictive of increased hospital cost (incremental increase in median hospital cost estimated at $11,075; 95% confidence interval, $3,282-$20,099).

CONCLUSIONS

Early infection with rGNR is associated with a high economic burden, which is in part related to increased antibiotic utilization compared with infection with sensitive organisms. Efforts to control overuse of antibiotics should be pursued.

摘要

目的

对至少一类主要抗生素耐药的革兰氏阴性菌(rGNR)感染对患者发病率的影响是否大于敏感菌株(sGNR)感染所致尚不清楚。我们希望检验rGNR感染与更高资源利用率相关的假设。

设计

对前瞻性收集的数据进行回顾性观察队列研究。

地点

大学医院外科重症监护病房和病房。

患者

至少发生一次GNR感染的外科患者。

测量

我们比较了接受rGNR感染治疗的入院患者和sGNR感染患者。主要结局为总住院费用和住院时间。其他结局包括抗生素治疗费用、院内死亡和重症监护病房住院时间。在对rGNR感染后与sGNR感染后的结局进行单因素分析后,建立了住院费用和住院时间的多变量线性回归模型以考虑潜在混杂因素。

主要结果

有604例因至少一次GNR感染接受治疗的外科入院患者(符合疾病控制和预防中心标准)有费用数据,其中137例(23%)为rGNR感染。rGNR感染的入院患者在感染时病情严重程度更高(急性生理与慢性健康状况评估II评分,17.6±0.6对13.9±0.3),中位住院费用更高(80,500美元对29,604美元,p<0.0001),中位抗生素费用更高(2,607美元对758美元,p<0.0001),中位住院时间更长(29天对13天,p<0.0001),中位重症监护病房住院时间更长(13天对1天,p<0.0001)。入院后7天内发生rGNR感染可独立预测住院费用增加(估计中位住院费用增量为11,075美元;95%置信区间,3,282美元至20,099美元)。

结论

早期rGNR感染与高经济负担相关,这部分与敏感菌感染相比抗生素使用增加有关。应努力控制抗生素的过度使用。

相似文献

1
Cost of Gram-negative resistance.革兰氏阴性菌耐药的代价。
Crit Care Med. 2007 Jan;35(1):89-95. doi: 10.1097/01.CCM.0000251496.61520.75.
2
Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.革兰氏阴性杆菌耐药菌感染对住院患者预后的影响。
Crit Care Med. 2003 Apr;31(4):1035-41. doi: 10.1097/01.CCM.0000060015.77443.31.
3
Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.郊区医疗中心重症监护病房患者呼吸机相关性肺炎的结局及归因成本
Crit Care Med. 2003 May;31(5):1312-7. doi: 10.1097/01.CCM.0000063087.93157.06.
4
Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay.压疮、医院并发症与疾病严重程度:对医院成本和住院时间的影响。
Adv Wound Care. 1999 Jan-Feb;12(1):22-30.
5
Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.非教学医院重症监护患者中导管相关血流感染的归因成本
Crit Care Med. 2006 Aug;34(8):2084-9. doi: 10.1097/01.CCM.0000227648.15804.2D.
6
Hospital mortality rate and length of stay in patients admitted at night to the intensive care unit.夜间入住重症监护病房患者的医院死亡率和住院时间。
Crit Care Med. 2003 Mar;31(3):858-63. doi: 10.1097/01.CCM.0000055378.31408.26.
7
Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.重症监护病房经验性抗生素轮换方案对非重症监护病房医院获得性感染发生情况的影响
Crit Care Med. 2004 Jan;32(1):53-60. doi: 10.1097/01.CCM.0000104463.55423.EF.
8
Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.与基于药效动力学的呼吸机相关性肺炎经验性抗生素选择临床路径相关的住院时间和住院费用。
Pharmacotherapy. 2010 May;30(5):453-62. doi: 10.1592/phco.30.5.453.
9
Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?基于证据的脓毒症治疗方案的经济影响:我们能否改善治疗结果并降低成本?
Crit Care Med. 2007 May;35(5):1257-62. doi: 10.1097/01.CCM.0000261886.65063.CC.
10
Cost of intensive care unit-acquired bloodstream infections.重症监护病房获得性血流感染的成本。
J Hosp Infect. 2006 Jun;63(2):124-32. doi: 10.1016/j.jhin.2005.12.016. Epub 2006 Apr 18.

引用本文的文献

1
The Economics of Antibiotic Resistance: A Systematic Review and Meta-analysis Based on Global Research.抗生素耐药性的经济学:基于全球研究的系统评价与荟萃分析
Appl Health Econ Health Policy. 2025 Aug 30. doi: 10.1007/s40258-025-01001-7.
2
Short course antibiotic treatment of Gram-negative bacteraemia (GNB5): a study protocol for a randomised controlled trial.短程抗生素治疗革兰氏阴性菌血症(GNB5):一项随机对照试验的研究方案。
BMJ Open. 2023 May 8;13(5):e068606. doi: 10.1136/bmjopen-2022-068606.
3
Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections.
临床和分子分析复发性革兰氏阴性菌血流感染。
Clin Infect Dis. 2023 Feb 8;76(3):e1285-e1293. doi: 10.1093/cid/ciac638.
4
Infections and antimicrobial resistance in an adult intensive care unit in a Brazilian hospital and the influence of drug resistance on the thirty-day mortality among patients with bloodstream infections.巴西某医院成人重症监护病房的感染和抗菌药物耐药情况,以及耐药性对血流感染患者 30 天死亡率的影响。
Rev Soc Bras Med Trop. 2020 Jun 22;53:e20190106. doi: 10.1590/0037-8682-0106-2019. eCollection 2020.
5
Implementation and impact of pediatric antimicrobial stewardship programs: a systematic scoping review.儿科抗菌药物管理计划的实施和影响:系统范围界定审查。
Antimicrob Resist Infect Control. 2020 Jan 3;9(1):3. doi: 10.1186/s13756-019-0659-3. eCollection 2020.
6
Impact of Multi-Drug-Resistant Pneumonia on Outcomes of Critically Ill Trauma Patients.多药耐药性肺炎对重症创伤患者结局的影响。
Surg Infect (Larchmt). 2020 Jun;21(5):422-427. doi: 10.1089/sur.2019.240. Epub 2020 Jan 2.
7
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin.肾功能损害及人有机阴离子转运体抑制对瑞巴坦与亚胺培南西司他丁联合用药的药代动力学、安全性及耐受性的影响
Br J Clin Pharmacol. 2020 May;86(5):944-957. doi: 10.1111/bcp.14204. Epub 2020 Jan 23.
8
Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: An updated meta-analysis.降钙素原指导下的慢性阻塞性肺疾病急性加重期抗生素治疗:一项更新的荟萃分析。
Medicine (Baltimore). 2019 Aug;98(32):e16775. doi: 10.1097/MD.0000000000016775.
9
Perioperative prophylaxis with ertapenem reduced infections caused by extended-spectrum betalactamase-producting Enterobacteriaceae after kidney transplantation.厄他培南围手术期预防用药可降低肾移植术后产超广谱β-内酰胺酶肠杆菌科细菌感染。
BMC Nephrol. 2019 Jul 22;20(1):274. doi: 10.1186/s12882-019-1461-4.
10
Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria.广泛耐药革兰阴性菌的流行病学及耐药机制
Antibiotics (Basel). 2019 Apr 6;8(2):37. doi: 10.3390/antibiotics8020037.